Obesity is a serious public health concern. More than half of British adults are overweight, and obesity among preschool children has increased by an alarming 70% in the past generation.
More than half of the parents of obese children expressed some degree of concern about their child's weight, but only a quarter were even "a little worried" if their child was overweight. Most parents (86%) who were unaware that their child was overweight, were also unconcerned about their child's weight. One in ten parents expressed some concern about underweight in normal weight children.
Prevalence of overweight in parents in the highest and lowest socioeconomic groups did not differ-59% in classes I and II were overweight compared with 62% in classes VI, VII, and VIII (P = 0.63; National Statistics Socioeconomic Classification 2001). Neither was there a difference in correct perception of the child's weight between socioeconomic groups (78% v 82%, P = 0.34).
Comment
Overweight goes largely unrecognised; parents are poor at identifying overweight in themselves and their children, and less likely to identify overweight in sons. The reasons for poor awareness might include denial, reluctance to admit a weight problem, or desensitisation to excess weight because being overweight has become normal. Obesity is now a problem across all social groups. Our data confirm recent findings indicating that the longstanding inverse relationship between social class and obesity has been lost, at least in the United Kingdom.
5
Acknowledgment of excess weight and an understanding of its health consequences are essential first steps in tackling obesity. The layperson's perception of average weight, however, now conflicts with the clinical definition of normal weight, and a label of overweight from a health professional may be insufficient motivation for a change in lifestyle. The apparent lack of parental concern about their child being overweight probably stems from a lack of awareness. Until this is resolved, we are missing critical partners in our efforts to stem an impending health crisis. BMI=body mass index. *Parents were correct if they thought their child's weight was "about right." †Parents were correct if they thought their child's weight was either "a little" or "very" overweight. In England, the low prevalence of HIV among injecting drug users during the 1990s was attributed in part to the introduction of harm reduction interventions in the late 1980s. Also, the prevalence of hepatitis C virus in the late 1990s was thought to be relatively low compared with other countries, at around 40% overall and 15% among those who had been injecting drugs for less than six years. 1 We carried out a prospective cohort study of new injecting drug users in London to estimate the incidence of hepatitis C virus and HIV.
Participants, methods, and results
In 2001, we recruited from community settings mainly in London, but also in Brighton, 428 injecting drug users who were aged below 30 years or had been injecting for six years or fewer. All had injected in the previous four weeks and could provide addresses for follow up. They completed interviewer administered questionnaires and provided oral fluid specimens and optionally dried capillary blood spots for testing for antibodies to hepatitis C virus and HIV using published methods. They were followed up 12 months later. We calculated incidence using standard person time methods.
Most of the participants (91%) were recruited in London. The mean (SD) age was 27.4 (5.3) years, and 29% of the participants were women. Three fifths (61%) of the sample at baseline had been injecting for less than four years, and the median frequency of injecting was 2.5 times a day. Most (71%) mainly injected opiates, although just over half (53%) had injected cocaine or crack in the previous year. Participants reported high levels of injecting risk behaviour, with 24% at baseline reporting injecting in the previous four weeks with needles and syringes used by someone else, and 53% sharing injecting paraphernalia. The baseline prevalence of antibody to hepatitis C virus was 44% and of antibody to HIV was 4% (table) .
The overall follow up rate was 70%, and we found no difference between those followed up and those lost to follow up for sociodemographic characteristics or injecting risk behaviour. The incidence of antibody to hepatitis C virus was 41.8 cases per 100 person years and of antibody to HIV was 3.4 cases per 100 person years (see table) .
Comment
The incidence of hepatitis C virus in England is high and of HIV higher than expected. These findings are corroborated by ongoing surveillance data, and suggest that transmission may have recently increased.
1
Injecting drug users in London have a higher incidence of hepatitis C virus than those in many cities worldwide, and an incidence of HIV comparable to that among men who have sex with men attending clinics for sexually transmitted infection in London. 4 Possible explanations for the rising incidence include changes in patterns of injecting drug use, with greater injection of crack and injecting risk behaviour in newer injecting drug users than in those injecting in the early to mid-1990s. In addition there may have been increases in the size of the population of injecting drug users over and above any increase in protective interventions. Recent estimates suggest that current 
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